Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 6/20 | 0.54 |
| ▸ | MEN1 | O00255 | 5/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | CNR2 | P34972 | 2/20 | 0.50 |
| ▸ | KDM4A | O75164 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.43 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.43 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15417604 | 0.92 | MAPT (0.55) | MAPTKMT2ANPSR1MEN1POLB | |
| SCHEMBL9608524 | 0.86 | KMT2A (0.50) | MAPTKMT2ANPSR1MEN1POLB | |
| SCHEMBL9608518 | 0.85 | TSHR (0.47) | MAPTKMT2ANPSR1MEN1POLB | |
| SCHEMBL9608487 | 0.84 | MEN1 (0.60) | MAPTKMT2ANPSR1MEN1POLB | |
| SCHEMBL9609340 | 0.83 | MEN1 (0.47) | MAPTKMT2ANPSR1MEN1POLB | |
| SCHEMBL9609235 | 0.83 | NOTUM (0.48) | MAPTKMT2ANPSR1MEN1POLB | |
| SCHEMBL9608531 | 0.83 | KMT2A (0.56) | MAPTKMT2ANPSR1MEN1POLB | |
| SCHEMBL9608519 | 0.83 | MAPT (0.47) | MAPTKMT2ANPSR1MEN1POLB | |
| SCHEMBL9608420 | 0.82 | MAPT (0.58) | MAPTKMT2ANPSR1MEN1POLB | |
| SCHEMBL15910001 | 0.82 | MAPT (0.60) | MAPTKMT2ANPSR1MEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2460799-B1 | NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION | FUJIFILM CORP (JP) | 2018-05-02 | — | — | EP | disclosed |
| US-8957140-B2 | Triazine derivative, ultraviolet absorber, and resin composition | FUJIFILM CORPORATION (JP) | 2015-02-17 | — | — | US | disclosed |
| US-8748520-B2 | Polycarbonate resin composition containing triazine compound and molded article using the same | FUJIFILM CORPORATION (JP) | 2014-06-10 | — | — | US | disclosed |
| US-8623990-B2 | Polyester resin composition | FUJIFILM CORPORATION (JP) | 2014-01-07 | — | — | US | disclosed |
| US-20120301696-A1 | POLYESTER RESIN COMPOSITION | FUJIFILM CORPORATION (JP) | 2012-11-29 | — | — | US | disclosed |
| US-20120136098-A1 | NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION | FUJIFILM CORPORATION (JP) | 2012-05-31 | — | — | US | disclosed |
| US-20110077331-A1 | POLYCARBONATE RESIN COMPOSITION CONTAINING TRIAZINE COMPOUND AND MOLDED ARTICLE USING THE SAME | FUJIFILM CORPORATION (JP) | 2011-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120136098-A1 | NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION | C1R, RPSA, H1-2 | MAPT 1774/4885KMT2A 1270/4885NPSR1 937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.